{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:08:14Z","timestamp":1793520494236,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Physicians World Europe GmbH, Mannheim, Germany"},{"name":"Roche Pharma AG, Grenzach-Wyhlen, Germany"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejca.2017.07.016","type":"journal-article","created":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T13:47:16Z","timestamp":1501940836000},"page":"69-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":221,"special_numbering":"C","title":["Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3297-5801","authenticated-orcid":false,"given":"Sebastian","family":"Stintzing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Tejpar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Thiebach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Josef","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejca.2017.07.016_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2017.07.016_bib2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2017.07.016_bib3","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2017.07.016_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-113-10-779","article-title":"Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location","volume":"113","author":"Bufill","year":"1990","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ejca.2017.07.016_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jso.20156","article-title":"Two colons-two cancers: paradigm shift and clinical implications","volume":"88","author":"Gervaz","year":"2004","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2017.07.016_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.10635","article-title":"Are there two sides to colorectal cancer?","volume":"101","author":"Iacopetta","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2017.07.016_bib7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/1471-2407-10-688","article-title":"Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes","volume":"10","author":"Hemminki","year":"2010","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2017.07.016_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju427","article-title":"Primary tumor location as a prognostic factor in metastatic colorectal cancer","volume":"107","author":"Loupakis","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ejca.2017.07.016_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000443644","article-title":"Right sided colon cancer as a distinct histopathological subtype with reduced prognosis","volume":"33","author":"Nitsche","year":"2016","journal-title":"Dig Surg"},{"issue":"6","key":"10.1016\/j.ejca.2017.07.016_bib10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/cncr.29129","article-title":"Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?","volume":"121","author":"Price","year":"2015","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.ejca.2017.07.016_bib11","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1158\/1078-0432.CCR-15-0527","article-title":"Analysis of molecular markers by anatomic tumor site in stage III colon carcinomas from adjuvant chemotherapy trial NCCTG N0147 (alliance)","volume":"21","author":"Sinicrope","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"Suppl.; abstr 3504","key":"10.1016\/j.ejca.2017.07.016_bib12","article-title":"Impact of primary (1\u00ba) tumor location on overall survival (OS) and progression free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): analysis of CALGB\/SWOG 80405 (Alliance)","volume":"34","author":"Venook","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2017.07.016_bib13","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.clcc.2016.02.007","article-title":"Impact of primary tumor site on bevacizumab efficacy in metastatic colorectal cancer","volume":"15","author":"Wong","year":"2016","journal-title":"Clin Colorectal Cancer"},{"issue":"Suppl. 6","key":"10.1016\/j.ejca.2017.07.016_bib14","first-page":"vi15","article-title":"Primary tumor sidedness impacts on prognosis and treatment outcome: results from three randomized studies of panitumumab plus chemotherapy versus chemotherapy or chemotherapy plus bevacizumab in 1st and 2nd line RAS\/BRAF WT mCRC","volume":"27","author":"Boeckx","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2017.07.016_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/CAD.0000000000000041","article-title":"Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment)","volume":"25","author":"Modest","year":"2014","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ejca.2017.07.016_bib16","article-title":"Prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: retrospective analyses of the CRYSTAL and FIRE-3 trials","author":"Tejpar","year":"2016","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2017.07.016_bib17","first-page":"384","article-title":"Right-sided colon cancer and left-sided colorectal cancers respond differently to cetuximab","volume":"34","author":"Wang","year":"2015","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.ejca.2017.07.016_bib18","series-title":"Embryology gastrointestinal tract development","author":"Hill","year":"2016"},{"key":"10.1016\/j.ejca.2017.07.016_bib19","series-title":"Langman's medical embryology","author":"Sadler","year":"2014"},{"issue":"11","key":"10.1016\/j.ejca.2017.07.016_bib20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ejca.2017.07.016_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1440-169x.2002.00623.x","article-title":"Region-specific gastrointestinal Hox code during murine embryonal gut development","volume":"44","author":"Kawazoe","year":"2002","journal-title":"Dev Growth Differ"},{"issue":"10","key":"10.1016\/j.ejca.2017.07.016_bib22","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/annonc\/mdu275","article-title":"Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features","volume":"25","author":"Missiaglia","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2017.07.016_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fmicb.2015.00020","article-title":"Microbiota disbiosis is associated with colorectal cancer","volume":"6","author":"Gao","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ejca.2017.07.016_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1186\/s12879-014-0733-7","article-title":"Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia","volume":"14","author":"Kohoutova","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.ejca.2017.07.016_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/aje\/kwr331","article-title":"Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany","volume":"175","author":"Zhang","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"24","key":"10.1016\/j.ejca.2017.07.016_bib26","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/jnci\/djt300","article-title":"Human gut microbiome and risk for colorectal cancer","volume":"105","author":"Ahn","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"51","key":"10.1016\/j.ejca.2017.07.016_bib27","doi-asserted-by":"crossref","first-page":"18321","DOI":"10.1073\/pnas.1406199111","article-title":"Microbiota organization is a distinct feature of proximal colorectal cancers","volume":"111","author":"Dejea","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.ejca.2017.07.016_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/gutjnl-2015-309595","article-title":"Tumour-associated and non-tumour-associated microbiota in colorectal cancer","volume":"66","author":"Flemer","year":"2017","journal-title":"Gut"},{"issue":"33","key":"10.1016\/j.ejca.2017.07.016_bib29","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1200\/JCO.2011.36.4414","article-title":"Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results\u2013medicare data","volume":"29","author":"Weiss","year":"2011","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.ejca.2017.07.016_bib30","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.3748\/wjg.v21.i21.6470","article-title":"Different treatment strategies and molecular features between right-sided and left-sided colon cancers","volume":"21","author":"Shen","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.ejca.2017.07.016_bib31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/jso.23895","article-title":"Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers","volume":"111","author":"Lan","year":"2015","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2017.07.016_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/gutjnl-2011-300865","article-title":"Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum","volume":"61","author":"Yamauchi","year":"2012","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.ejca.2017.07.016_bib33","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1158\/0008-5472.CAN-14-0013","article-title":"Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer","volume":"74","author":"Mouradov","year":"2014","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.ejca.2017.07.016_bib34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S1542-3565(05)00618-X","article-title":"Refining molecular analysis in the pathways of colorectal carcinogenesis","volume":"3","author":"Rowan","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.ejca.2017.07.016_bib35","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/bjc.2016.87","article-title":"Association of CpG island methylator phenotype and EREG\/AREG methylation and expression in colorectal cancer","volume":"114","author":"Lee","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2017.07.016_bib36","article-title":"Targeted therapy using trastuzumab will overcome chemotherapeutic failure in liver metastasis of colorectal cancer","author":"Mayer","year":"2015","journal-title":"Eur Surg Res"},{"key":"10.1016\/j.ejca.2017.07.016_bib37","article-title":"Association of primary (1\u00b0) site and molecular features with progression-free survival (PFS) and overall survival (OS) of metastatic colorectal cancer (mCRC) after anti-epidermal growth factor receptor (\u03b1EGFR) therapy","volume":"34","author":"Lee MSA","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6B","key":"10.1016\/j.ejca.2017.07.016_bib38","first-page":"3865","article-title":"VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival","volume":"28","author":"Bendardaf","year":"2008","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.ejca.2017.07.016_bib39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3816\/CCC.2004.n.005","article-title":"Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy","volume":"3","author":"Nasir","year":"2004","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ejca.2017.07.016_bib40","series-title":"Colon cancer","year":"2017"},{"key":"10.1016\/j.ejca.2017.07.016_bib41","article-title":"Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis","author":"Petrelli","year":"2016","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2017.07.016_bib42","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00432-014-1678-3","article-title":"Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12\/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial","volume":"140","author":"von Einem","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"issue":"13","key":"10.1016\/j.ejca.2017.07.016_bib43","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1158\/1078-0432.CCR-15-2422","article-title":"Prognostic impact of IL6 genetic variants in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy","volume":"22","author":"Matsusaka","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"Suppl.","key":"10.1016\/j.ejca.2017.07.016_bib44","article-title":"Primary tumor location and efficacy of second-line therapy after initial treatment with FOLFIRI in combination with cetuximab or bevacizumab in patients with metastatic colorectal cancer- FIRE-3 (AIOKRK0306)","volume":"35","author":"Modest","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.07.016_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2016.10.007","article-title":"The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials","volume":"70","author":"Holch","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2017.07.016_bib46","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2016.34.4_suppl.550","article-title":"Treatment patterns and outcomes in patients with KRAS wild type (WT) metastatic colorectal cancer (mCRC) treated in first line with bevacizumab (B) or cetuximab (C) containing regimens","volume":"34","author":"Houts","year":"2016","journal-title":"J Clin Oncol"},{"issue":"Suppl. 4S; abstr 493","key":"10.1016\/j.ejca.2017.07.016_bib47","article-title":"MAVERICC, a phase 2 study of mFOLFOX6bevacizumab (BV) vs FOLFIRIBV with biomarker stratification as firstline (1L) chemotherapy (CT) in patients (pts) with metastatic colorectal cancer (mCRC)","volume":"34","author":"Lenz","year":"2016","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2017.07.016_bib48","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ejca.2015.03.015","article-title":"Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17","volume":"51","author":"Brule","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2017.07.016_bib49","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.3517","article-title":"HER2 amplification as a negative predictive biomarker for anti-epidermal growth factor receptor antibody therapy in metastatic colorectal cancer","volume":"34","author":"Raghav","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2017.07.016_bib50","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/1097-0215(20001115)88:4<614::AID-IJC15>3.0.CO;2-0","article-title":"Genetic alterations in DNA diploid, aneuploid and multiploid colorectal carcinomas identified by the crypt isolation technique","volume":"88","author":"Sugai","year":"2000","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2017.07.016_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/ajco.12469","article-title":"Primary tumor location is an important predictive factor for wild-type KRAS metastatic colon cancer treated with cetuximab as front-line bio-therapy","volume":"12","author":"Lu","year":"2016","journal-title":"Asia Pac J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917311267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917311267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T22:25:51Z","timestamp":1569968751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917311267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":51,"alternative-id":["S0959804917311267"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.07.016","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}